By: Quiver EarningsTracker
Posted: 3 hours ago / Sept. 19, 2026 9:05 p.m. UTC
BENITEC BIOPHARMA ($BNTC) is expected to release its quarterly earnings data on Monday, September 21st after market close, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$0.28 per share.
You can see Quiver Quantitative’s $BNTC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EARLY ACCESS
Receive BNTC Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
BENITEC BIOPHARMA Hedge Fund Activity
We have seen 50 institutional investors add shares of BENITEC BIOPHARMA stock to their portfolio, and 36 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIREN, L.L.C. removed 775,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,253,750
- SIMPLIFY ASSET MANAGEMENT INC. added 443,315 shares (+78.8%) to their portfolio in Q2 2026, for an estimated $5,931,554
- NANTAHALA CAPITAL MANAGEMENT, LLC added 400,000 shares (+38.5%) to their portfolio in Q1 2026, for an estimated $4,260,000
- MILLENNIUM MANAGEMENT LLC added 269,235 shares (+41.3%) to their portfolio in Q2 2026, for an estimated $3,602,364
- BLACKROCK, INC. added 221,397 shares (+18.7%) to their portfolio in Q2 2026, for an estimated $2,962,291
- CITADEL ADVISORS LLC added 154,142 shares (+876.8%) to their portfolio in Q1 2026, for an estimated $1,641,612
- LONGAEVA PARTNERS L.P. removed 110,126 shares (-88.1%) from their portfolio in Q2 2026, for an estimated $1,473,485
To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.